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titis. Secondly, to evaluate the readmission rate with biliary complications
that occur due to a delay in surgical management; and thirdly, to estimate
the ﬁnancial cost resulting from the recurrent admissions and subsequent
investigations.
Methods: A retrospective analysis included patients with gallstones
pancreatitis whowere admitted across a local trust between June 2011 and
January 2013. Patients with severe pancreatitis and those unﬁt for surgery
were excluded.
Results: 40 patients were included in the study. 45% of patients readmitted
with biliary complications. Only 1 patient (2.5%) had cholecystectomy
within 2 weeks of admission as per guidelines. Estimated cost of extra
investigations required during readmissions exceeded £20,000.
Conclusions: There is an evident breach regards timing of cholecystectomy
following mild gallstones pancreatitis in accordance with the guidelines,
with a compliance rate of 2.5%. This has resulted in high readmission rate
with biliary complications, and subsequently a high extra cost.
0086: SYSTEMATIC REVIEW OF THE VALUE OF LYMPH NODE RATIO AS
AN INDEPENDENT PROGNOSTIC INDICATOR IN RESECTABLE PERIAM-
PULLARY TUMOURS
Justin Ong *,1, Chuan Jin Tan 1, Shahid Farid 2, Gavin Falk 3,
R Matthew Walsh 3, Gareth Morris-Stiff 3. 1Belfast City Hospital, Belfast,
Co Antrim, UK; 2Kettering General Hospital, Kettering, Northamptonshire, UK;
3Cleveland Clinic Foundation, Cleveland, Ohio, USA.
Introduction: Several recent studies suggests that the lymph node ratio
(LNR) is of greater prognostic value compared to lymph node status in
patients undergoing resection of periampullary carcinomas. Our aim was
to review all current available evidence regarding the value of LNR as an
independent prognostic indicator for periampullary tumours.
Methods: A comprehensive review of the literature on papers published
up until the end of December 2012 that included outcome data in relation
to LNR were evaluated. Data were extracted and pooled hazard ratio (HR)
analysis was performed to determine the relationship between LNR and
overall survival.
Results: Fourteen studies were identiﬁed (7566 patients). Pooled analysis
of the HR of studies performing multivariate analysis with LNR cut off
values of 0.2 and 0.3 demonstrated an increase in HR from 1.52 (1.25-1.84)
to 1.66 (1.35-2.05) respectively. LNR was reported to be an independent
and powerful prognostic indicator in all but one study. Seven studies re-
ported that an increase in LNR is signiﬁcantly associated with a worse
prognosis. Three studies that measured disease-free survival all reported a
worse disease-free survival as LNR increased.
Conclusions: LNR is an important and independent predictor of overall
survival in periampullary tumours. Further studies are required to deter-
mine the LNR that provides the greatest prognostic information.
0096: MANAGEMENT OF GALLBLADDER POLYPS IN A DISTRICT GEN-
ERAL HOSPITAL
Anna Bradley*, Aimen Amer, Christopher Nettleship, Robin Brown,
Hisham Hurreiz. Department of Surgery, Daisy Hill Hospital, Southern
Health and Social Care Trust, Newry, UK.
Introduction: Early detection and surveillance of gallbladder polyps can
reduce the risk of progression to gallbladder malignancy, which carries a
poor prognosis. A recently published review recommends regular ultra-
sound follow-up for polyps between 6-10mm in diameter, cholecystec-
tomy for those >10mm and no follow-up for polyps <6mm. Our aimwas to
evaluate the practice of gallbladder polypmanagement in a district general
hospital over a three-year period.
Methods: Patients who had gallbladder polyps diagnosed on ultrasound
between 2010 and 2013 were identiﬁed from the electronic reporting
system. Data was retrospectively collected for these cases including
sonographic and operative details.
Results: One hundred and forty six patients were included. The mean age
at diagnosis was 50 years and the male:female ratio was 1:1.9. 20% of cases
had polyps between 6-10mm. Of these, only 41% had a follow-up ultra-
sound within 12 months. 78% of cases had polyps <6mm, yet 38% of these
had a follow-up scan. Polyps >10mm were identiﬁed in two patients to
whom cholecystectomy was offered.
Conclusions: Our surveillance practice for gallbladder polyps is currently
suboptimal and inefﬁcient based on current recommendations in theliterature. Clear national guidelines on the management of gallbladder
polyps will facilitate the reﬁnement and standardisation of practice.
0160: MANAGEMENT OF COLORECTAL LIVER METASTASIS IN IRELAND:
A NATIONAL ANALYSIS
Michael Kelly *,1, Tom Gallagher 1, Paul Ridgway 2, Oscar Traynor 1,
Donal Maguire 1, Justin Geoghegan 1. 1St Vincent's University Hospital,
Dublin, Ireland; 2The Adelaide & Meath Hospital, Tallaght, Dublin, Ireland.
Introduction: To examine the current practice & referral patterns of both
consultant surgeons/oncologists and multi-disciplinary meetings (MDM)
around Ireland in respect to the management of CLM.
Methods: A three-way approach was employed: 1) Assessment of the
number of CLM resections performed nationally (2005-2011). 2) An online
survey of consultant surgeons/oncologists, assessing their practice, & re-
ferrals criteria to dedicated HPB-centres. 3) A review of relevant MDM’s
nationally inquiring details regarding CLM patients and subsequent
management for November 2012 & February 2013.
Results: During 2005-2011, an annual mean of 1,467 underwent colorectal
resection. During the same period only 63 CLM-resections on average
annually were performed. Response to the consultant survey was 61.2%.
Main negative factors for referral included; age, co-morbidities, bilobar
disease, >5 lesions, and CEA>60 ng/ml. 8 of 11 specialist centres replied. In
November-2012; 234 patients were discussed at MDM. 39 (16.6%) had
CLM, 33.3% which were subsequently referred to a HPB-centre, with 5
(12.8%) referred to oncology and the remaining 53.9% palliative. Similar
results were reported for February 2013.
Conclusions: CLM resection rates in Ireland remain low. Reasons include
lack of consensus on resectability, and recognized referral pathways.
Negative referral factors in some instance are outdated. MDM’s provide
both consistent and coordinated care-pathway with excellent links to
dedicated HPB-centres.
0307: BSG GUIDELINE COMPLIANCE FOR THE MANAGEMENT OF GALL-
STONE PANCREATITIS e A CHANGE IN PRACTICE WITH ROOM FOR
IMPROVEMENT?
Robert Spence*, Kevin McElvanna, Ian McAllister. Ulster Hospital,
Dundonald, Belfast, UK.
Introduction: The British Society of Gastroenterology (BSG) set standards
for the management of acute pancreatitis. A previous audit demonstrated
40.5% compliance with guidelines for deﬁnitive intervention of biliary
pancreatitis within two weeks. We have evaluated our change in practice
following this study.
Methods: Data were obtained retrospectively for 110 consecutive patients
admitted with acute pancreatitis during a nine month period, and their
management evaluated against the guidelines.
Results: One hundred and ten patients (63 male) were admitted with
acute pancreatitis during a nine month period, with mean age 54.7 years.
Pancreatitis was secondary to gallstones in 51 patients. Ten patients (9.1%)
had severe pancreatitis, six died. Mean length of stay of gallstone
pancreatitis patients was 9.3 days (range 2-78 days). Intervention
included: ERCP (13 patients, mean inpatient wait 6.4 days, outpatient 42
days); cholecystectomy (24 patients, mean wait: 12.5 days (range 1-81
days)). Therewas 75% compliance with BSG guidelines regarding deﬁnitive
intervention within 2 weeks.
Conclusions: Following the addition of supplementary cholecystectomy
lists and a conversion to ‘surgeon of the week’ admission policy, this study
demonstrated improvement (40.5% to 75%) over the previous audit for
intervention for biliary pancreatitis. Further delays could be prevented by
expediting ERCP waiting times.
0369: LIVER RESECTION FOR METASTATIC GASTROINTESTINAL STRO-
MAL TUMOURS: PRE-TREATMENT CLASSIFICATION AND LONG-TERM
OUTCOME
I. Sarantitis*,1, P.O. Coe 1, D.A. O'Reilly 1, M.G. Leahy 2, D.J. Sherlock 1. 1North
Manchester General Hospital, The Pennine Acute NHS Trust, Manchester, UK;
2The Christie NHS Foundation Trust, Manchester, UK.
Introduction: GISTs are a rare tumour for which adjuvant chemotherapy
with tyrosine kinase inhibitors has improved outcomes. Yet the precise
role for TKIs in pre-operative setting remains unclear. This study aimed to
review a single centre‘s outcomes of patients who underwent liver
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treatment classiﬁcation by Cananzi et al.
Methods: A retrospective case note analysis was performed. Pre-treatment
disease extent was classiﬁed as per Cananzi et al: type I-II non-metastatic,
resectable disease; III metastatic (synchronous) resectable disease; IV
unresectable disease. The primary outcome was 5-year survival; secondary
outcomes were disease free intervals and treatment practices.
Results: Twelve patients underwent liver resection for metastatic GISTs.
Pre-treatment, patients were classiﬁed as: type I in 3; type II in 5; type III in
2; type IV in 2. Five-year survival was 100%, 60%, 50% and 100% respec-
tively. Type I to III patients were treated with surgical resection only. Type
IV disease was downstaged with neo-adjuvant TKIs prior to resection. The
disease free interval was 73, 28, 28 and 53 months respectively (mean 36
months).
Conclusions: Neo-adjuvant TKIs therapy for metastatic GIST has a
potentially signiﬁcant role in improving 5-year survival and disease free
intervals.
0445: A CLOSED LOOP AUDIT DEMONSTRATES GREAT IMPROVEMENT
IN ACUTE PANCREATITIS CARE
Peter Davies*, Hareth Bader, Chris Battersby, Debashish Maitra. St Helens
and Knowsley NHS Trust, Merseyside, UK.
Introduction: The British Society of Gastroenterologists (BSG) updated
guidelinesonthemanagementofacutepancreatitis in2005. Thisaudit aimed
to improve acute pancreatitis care in accordance with those guidelines.
Methods: An initial audit of all 39 patients with acute pancreatitis in
October-December 2011 was undertaken. Improvements were made
through arranging group teaching for junior doctors, extra cholecystec-
tomy lists, a 7-days per week ultrasound service (5-days previously) and
combined microbiology and surgical ward rounds. Liaison with gastroen-
terologists improved ERCP availability. A retrospective re-audit was un-
dertaken of all 50 patients in February-March 2013 to complete the audit
cycle.
Results: Modiﬁed Glasgow Score was completed in 98% of re-audit cases
(85% previously). Antibiotic prescription was considered appropriate in
90% (47%). Gallstone pancreatitis was managed by cholecystectomy, either
as an inpatient or within two weeks, in 77% (10%). Ultrasound was per-
formed within 24 hours of admission in 66% (28%), ERCP was delayed in 2%
(5%) and overall mortality was 8% (10%).
Conclusions: Acute pancreatitis care was improved following several
changes. Current care follows recommended guidelines but there is room
for improvement, notably in improving ultrasound access and managing
gallstone pancreatitis.
0502: POST OPERATIVE SURGICAL DRAINS AFTER PANCREATICODUO-
DENECTOMY: SINGLE VERSUS DUAL DRAINAGE
Jamal Ghaddar*, William Paxton, Chris Briggs, Somaiah Aroori. Derriford
Hospital, Plymouth, UK.
Introduction: The placement of one or more abdominal drains after
pancreaticoduodenectomy is common practice with the rationale that this
facilitates early diagnosis of complications.
Increasing evidence suggests that drainage after abdominal surgeries may
be unnecessary.
Our aim was to evaluate the outcomes following the use of one drain
versus two drains following pancreaticoduodenectomy.
Methods: We retrospectively reviewed 182 patients chosen at random out
of a pool of 260 patients who had a pancreaticoduodenectomy between
2006 and 2013.
Patients were subdivided into two groups; those with one drain (group 1)
and patients with two drains (group 2). Data was then analysed according
to demographic factors such as age/gender and peri-operative factors such
as type of pancreatic anastomosis, date of drain removal, complications,
means used to diagnose and treat complications, length of stay, clinical
details, cancer origin and histology reports.
Results: There were 37 patients in group1 and 145 patients in group2. The
length of hospital stay was signiﬁcantly shorter in group 1 (13.16 vs 15.39
days, P<0.05). There was no statistical difference in the rate of overall
complications, intervention or re-admission in both groups.
Conclusions: The use of one drain after pancreaticoduodencetomy may
facilitate earlier discharge without increasing morbidity, mortality, re-
admission and intervention rate.0728: ROUTINE COAGULATION SCREENING IS UNNECESSARY PRIOR TO
ERCP IN NON-JAUNDICED PATIENTS; A MULTI-CENTRE STUDY
Sarah Walker*,2, Katie Mellor 2, Jonny Nicholls 1, Richard Egan 1,
Michael Stechman 1. 1University Hospital of Wales, Cardiff, UK; 2Princess of
Wales Hospital, Bridgend, UK.
Introduction: Guidelines suggest performing coagulation screening prior
to endoscopic retrograde cholangiopancreatography (ERCP). We
hypothesise that coagulation is rarely deranged in the absence of
biochemical jaundice.
Methods: All ERCP procedures performed at two centres during a 16
month period were assessed. For each patient demographic data, pre-
procedure bilirubin and prothrombin time (PT), diagnosis and bleeding
complications were recorded. Exclusion criteria were; incomplete records,
anti-coagulation therapy or inherited coagulopathy.
Results: The cohort was divided into jaundiced (n¼419) and non-jaun-
diced (n¼374) groups for analysis. Seven per cent (n¼28) of jaundiced
patients had a signiﬁcantly prolonged PT (>16.8 seconds ¼ INR of 1.5).
One non-jaundiced patient had signiﬁcantly prolonged PT, whilst 5.9 per
cent (n¼22) had a mildly raised PT (above normal range); none of these
had bleeding complications. A signiﬁcant difference in PT between groups
was seen (mean ±SD 13.0 ±6.3 vs. 11.0 ±1.2 seconds; p<0.001 t-test). The
diagnosis, ERCP procedures, and bleeding complications were equivalent
between groups and centres. The approximate cost of coagulation tests in
the non-jaundiced cohort was £7,500.
Conclusions: Patients with normal bilirubin levels rarely have deranged
coagulation suggestive of acquired coagulopathy. A negative bleeding
history and normal liver function tests makes coagulation screening an
unnecessary and expensive investigation.
0801: FITNESS TO DRIVE ADVICE AFTER ELECTIVE LAPAROSCOPIC CHO-
LECYSTECTOMY (ELC) e WHOSE RESPONSIBILITY IS IT? A SURVEY OF
CAR INSURANCE COMPANIES
Michael Courtney*, Bussa Gopinath, Duncan Light, Milind Rao. University
Hospital of North Tees, Stockton-on-Tees, UK.
Introduction: Easily accessible online advice regarding return to driving
following ELC is inconsistent. Driving too soon is unsafe and risks inva-
lidating a patient's car insurance; hence patients are often advised to
check their own insurance company's policy. This study aimed to review
UK insurance companies' advice regarding return to driving following
ELC.
Methods: An online search identiﬁed 126 car insurers; each was emailed
asking when the policyholder can return to driving following ELC, and
advice as to how he/she would know they were ﬁt to drive.
Results: 26 companies were not contactable online so excluded. Of the
remaining 100 companies, 62 responded: 61% stated their regulations, 39%
would not communicate without a conﬁrmed policy. All companies of-
fering information stated that a doctor must determine the policyholder's
ﬁtness to drive, or timescale in which they cannot. 1 stated that the poli-
cyholder needed to be able to perform an emergency stop, the rest did not
comment.
Conclusions: Insurance companies place the responsibility of determining
ﬁtness to return to driving with the patient's doctors. It is the doctor's duty
to ensure that patients have access to this information, and that infor-
mation is documented. If publically available information is to be utilised,
there is a need for standardisation.
0843: HEPATIC TRANSARTERIAL CHEMOEMBOLISATION IN EAST
LANCASHIRE: ACHIEVING INTERNATIONAL STANDARDS
Kenan Kursumovic*, Sam Byott, Ambareen Kausar, David Chang,
Neil Wilde, Duncan Gavan. Royal Blackburn Hospital, Blackburn, UK.
Introduction: Hepatic Transarterial Chemoembolisation (TACE) for non-
resectable Hepatocellular carcinoma (HCC) therapy exploits the prefer-
ential blood supply from the hepatic artery for delivery of antitumour
therapy. It is also used for other primary or metastatic liver malignancies.
We enacted a comprehensive review of the TACE service at a district
general hospital in East Lancashire, United Kingdom with a focus on pa-
tient selection, complications and survival rates.
Methods: A retrospective review was performed from 2007 to 2012,
against clinical practice guidelines published by CIRSE (2012) and SIR
(2012).
